Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Celldex Therapeutics, Inc. (CLDX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  4.77.43.69.512.76.85.53.6
            Revenue growth  -37.3%107.6%-62.5%-25.2%87.8%23.8%52.8%-12.8%
Cost of goods sold  0.10.20.10.70.71.60.90.0
Gross profit  4.67.23.58.812.05.24.63.6
            Gross margin  97.8%97.3%97.2%92.7%94.5%76.4%83.6%100.0%
Selling, general and administrative   [+]20.514.515.419.325.036.033.820.6
Research and development  53.342.542.766.496.2102.7100.2104.4
Other operating expenses  -0.1-0.21.7-19.4-0.7-0.60.11.0
EBITDA   [+]-66.1-45.6-51.5-53.9-104.0-128.8-125.5-119.0
            EBITDA margin  -1420.8%-615.3%-1440.4%-565.4%-816.3%-1898.4%-2290.7%-3319.3%
Depreciation  3.13.94.93.64.43.13.02.4
EBITA  -69.1-49.6-56.3-57.5-108.4-131.9-128.5-121.4
            EBITA margin  -1486.7%-668.3%-1576.4%-602.9%-850.9%-1944.0%-2345.4%-3385.9%
Amortization of intangibles     0.20.91.01.01.0
EBIT   [+]-69.1-49.6-56.3-57.7-109.3-132.9-129.5-122.4
            EBIT margin  -1486.7%-668.3%-1576.4%-605.2%-857.9%-1958.7%-2363.9%-3414.1%
Non-recurring items   [+]2.113.8-1.398.712.2   
Interest income  0.52.44.24.54.24.42.34.4
Pre-tax income  -70.7-60.9-50.9-151.9-117.3-128.5-127.2-118.1
Income taxes  -0.2-1.20.0-0.8-24.30.00.00.0
            Tax rate  0.3%1.9%0.0%0.5%20.7%0.0%0.0%0.0%
Net income  -70.5-59.8-50.9-151.2-93.0-128.5-127.2-118.1
            Net margin  -1516.0%-805.9%-1424.0%-1585.1%-730.1%-1894.0%-2321.1%-3292.8%
   
Basic EPS   [+]($1.64)($2.02)($3.51)($14.48)($10.86)($18.99)($1.31)($1.32)
Diluted EPS   [+]($1.64)($2.02)($3.51)($14.48)($10.86)($18.99)($1.31)($1.32)
   
Shares outstanding (basic)   [+]42.929.614.510.48.66.897.189.4
Shares outstanding (diluted)   [+]42.929.614.510.48.66.897.189.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy